11/10
12:53 pm
ghrs
GH Research (NASDAQ:GHRS) had its price target lowered by analysts at HC Wainwright from $40.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
GH Research (NASDAQ:GHRS) had its price target lowered by analysts at HC Wainwright from $40.00 to $35.00. They now have a "buy" rating on the stock.
11/8
01:18 pm
ghrs
Low
Report
11/6
07:23 am
ghrs
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Low
Report
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
11/6
07:00 am
ghrs
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
Low
Report
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
10/18
09:07 am
ghrs
AbbVie completes acquisition of Gilgamesh Pharmaceuticals' bretisilocin [Yahoo! Finance]
Medium
Report
AbbVie completes acquisition of Gilgamesh Pharmaceuticals' bretisilocin [Yahoo! Finance]
10/17
08:10 pm
ghrs
We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth [Yahoo! Finance]
Medium
Report
We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth [Yahoo! Finance]
10/14
07:58 am
ghrs
GH Research (NASDAQ:GHRS) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.
Low
Report
GH Research (NASDAQ:GHRS) was upgraded by analysts at Needham & Company LLC to a "moderate buy" rating.
10/13
07:03 am
ghrs
GH Research (NASDAQ:GHRS) was given a new $19.00 price target on by analysts at Needham & Company LLC.
Low
Report
GH Research (NASDAQ:GHRS) was given a new $19.00 price target on by analysts at Needham & Company LLC.
10/9
07:11 am
ghrs
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress [Yahoo! Finance]
Low
Report
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress [Yahoo! Finance]
10/9
07:00 am
ghrs
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
Low
Report
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress